Cui Liu , Qiusheng Jing , Li Wang , Qincheng Huang , Yukun Jie , Yutong Zheng , Tiantian Ye , Junjun Yan , Zhimin Gu
{"title":"饲料中添加虾青素对罗氏沼虾肠道菌群和代谢物、抗氧化能力及对虹彩十足病毒1型抗性的影响","authors":"Cui Liu , Qiusheng Jing , Li Wang , Qincheng Huang , Yukun Jie , Yutong Zheng , Tiantian Ye , Junjun Yan , Zhimin Gu","doi":"10.1016/j.fsi.2025.110704","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The appearance and cross-border dissemination of numerous pathogenic microorganisms have substantially hindered the sustainable growth of the prawn's farming industry. Nutritional regulation is considered a key strategy for improving disease resistance in aquatic animals.</div></div><div><h3>Aims</h3><div>A feeding trial was conducted to evaluate the effects of dietary astaxanthin on growth performance, intestinal microbiota and metabolites, antioxidant capacity, immune response, and resistance to decapod iridescent virus 1 (DIV1) in <em>Macrobrachium rosenbergii</em>.</div></div><div><h3>Methods</h3><div>Dietary supplementation with astaxanthin at doses of 0, 100 mg/kg, 500 mg/kg, and 1000 mg/kg was administered to prawns for 8 weeks, followed by a DIV1 challenge test. The effects were evaluated by analyzing the cumulative survival rate, intestinal microbiota and metabolites, plasma antioxidant indices, hepatopancreatic histology, and the expression levels of immune-related genes.</div></div><div><h3>Results</h3><div>The levels of astaxanthin were significantly increased in the intestine and hepatopancreas (<em>P</em> < 0.05). The relative abundance of <em>Lactococcus garvieae</em> decreased and 5-hydroxy-L-tryptophan level significantly increased in dietary astaxanthin groups (<em>P</em> < 0.05). Following the DIV1 challenge test, the cumulative survival rate was significantly increased in 500 mg/kg dietary astaxanthin group (<em>P</em> < 0.05). Plasma SOD and CAT activities were significantly increased in dietary astaxanthin groups (<em>P</em> < 0.05). Plasma MDA levels and apoptosis rate in hepatopancreas were significantly reduced in dietary astaxanthin groups (<em>P</em> < 0.05). The relative expression levels of <em>toll</em>, <em>myd88</em>, and <em>irf4</em> genes were significantly increased in astaxanthin supplemented groups (<em>P</em> < 0.05). Dietary astaxanthin did not significantly affect the growth performance of prawns.</div></div><div><h3>Conclusion</h3><div>Dietary astaxanthin has the potential to improve intestinal microbiota and metabolites, enhance antioxidant capacity, and strengthen MyD88-dependent Toll-signaling pathways for defense against DIV1. Overall, 500 mg/kg dietary astaxanthin was recommended to achieve the optimal health benefits for <em>M. rosenbergii</em>.</div></div>","PeriodicalId":12127,"journal":{"name":"Fish & shellfish immunology","volume":"166 ","pages":"Article 110704"},"PeriodicalIF":3.9000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The effects of dietary astaxanthin on the intestinal microbiota and metabolites, antioxidant capacity, and resistance to Decapod iridescent virus 1 in Macrobrachium rosenbergii\",\"authors\":\"Cui Liu , Qiusheng Jing , Li Wang , Qincheng Huang , Yukun Jie , Yutong Zheng , Tiantian Ye , Junjun Yan , Zhimin Gu\",\"doi\":\"10.1016/j.fsi.2025.110704\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>The appearance and cross-border dissemination of numerous pathogenic microorganisms have substantially hindered the sustainable growth of the prawn's farming industry. Nutritional regulation is considered a key strategy for improving disease resistance in aquatic animals.</div></div><div><h3>Aims</h3><div>A feeding trial was conducted to evaluate the effects of dietary astaxanthin on growth performance, intestinal microbiota and metabolites, antioxidant capacity, immune response, and resistance to decapod iridescent virus 1 (DIV1) in <em>Macrobrachium rosenbergii</em>.</div></div><div><h3>Methods</h3><div>Dietary supplementation with astaxanthin at doses of 0, 100 mg/kg, 500 mg/kg, and 1000 mg/kg was administered to prawns for 8 weeks, followed by a DIV1 challenge test. The effects were evaluated by analyzing the cumulative survival rate, intestinal microbiota and metabolites, plasma antioxidant indices, hepatopancreatic histology, and the expression levels of immune-related genes.</div></div><div><h3>Results</h3><div>The levels of astaxanthin were significantly increased in the intestine and hepatopancreas (<em>P</em> < 0.05). The relative abundance of <em>Lactococcus garvieae</em> decreased and 5-hydroxy-L-tryptophan level significantly increased in dietary astaxanthin groups (<em>P</em> < 0.05). Following the DIV1 challenge test, the cumulative survival rate was significantly increased in 500 mg/kg dietary astaxanthin group (<em>P</em> < 0.05). Plasma SOD and CAT activities were significantly increased in dietary astaxanthin groups (<em>P</em> < 0.05). Plasma MDA levels and apoptosis rate in hepatopancreas were significantly reduced in dietary astaxanthin groups (<em>P</em> < 0.05). The relative expression levels of <em>toll</em>, <em>myd88</em>, and <em>irf4</em> genes were significantly increased in astaxanthin supplemented groups (<em>P</em> < 0.05). Dietary astaxanthin did not significantly affect the growth performance of prawns.</div></div><div><h3>Conclusion</h3><div>Dietary astaxanthin has the potential to improve intestinal microbiota and metabolites, enhance antioxidant capacity, and strengthen MyD88-dependent Toll-signaling pathways for defense against DIV1. Overall, 500 mg/kg dietary astaxanthin was recommended to achieve the optimal health benefits for <em>M. rosenbergii</em>.</div></div>\",\"PeriodicalId\":12127,\"journal\":{\"name\":\"Fish & shellfish immunology\",\"volume\":\"166 \",\"pages\":\"Article 110704\"},\"PeriodicalIF\":3.9000,\"publicationDate\":\"2025-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Fish & shellfish immunology\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1050464825005935\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"FISHERIES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Fish & shellfish immunology","FirstCategoryId":"97","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1050464825005935","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"FISHERIES","Score":null,"Total":0}
The effects of dietary astaxanthin on the intestinal microbiota and metabolites, antioxidant capacity, and resistance to Decapod iridescent virus 1 in Macrobrachium rosenbergii
Background
The appearance and cross-border dissemination of numerous pathogenic microorganisms have substantially hindered the sustainable growth of the prawn's farming industry. Nutritional regulation is considered a key strategy for improving disease resistance in aquatic animals.
Aims
A feeding trial was conducted to evaluate the effects of dietary astaxanthin on growth performance, intestinal microbiota and metabolites, antioxidant capacity, immune response, and resistance to decapod iridescent virus 1 (DIV1) in Macrobrachium rosenbergii.
Methods
Dietary supplementation with astaxanthin at doses of 0, 100 mg/kg, 500 mg/kg, and 1000 mg/kg was administered to prawns for 8 weeks, followed by a DIV1 challenge test. The effects were evaluated by analyzing the cumulative survival rate, intestinal microbiota and metabolites, plasma antioxidant indices, hepatopancreatic histology, and the expression levels of immune-related genes.
Results
The levels of astaxanthin were significantly increased in the intestine and hepatopancreas (P < 0.05). The relative abundance of Lactococcus garvieae decreased and 5-hydroxy-L-tryptophan level significantly increased in dietary astaxanthin groups (P < 0.05). Following the DIV1 challenge test, the cumulative survival rate was significantly increased in 500 mg/kg dietary astaxanthin group (P < 0.05). Plasma SOD and CAT activities were significantly increased in dietary astaxanthin groups (P < 0.05). Plasma MDA levels and apoptosis rate in hepatopancreas were significantly reduced in dietary astaxanthin groups (P < 0.05). The relative expression levels of toll, myd88, and irf4 genes were significantly increased in astaxanthin supplemented groups (P < 0.05). Dietary astaxanthin did not significantly affect the growth performance of prawns.
Conclusion
Dietary astaxanthin has the potential to improve intestinal microbiota and metabolites, enhance antioxidant capacity, and strengthen MyD88-dependent Toll-signaling pathways for defense against DIV1. Overall, 500 mg/kg dietary astaxanthin was recommended to achieve the optimal health benefits for M. rosenbergii.
期刊介绍:
Fish and Shellfish Immunology rapidly publishes high-quality, peer-refereed contributions in the expanding fields of fish and shellfish immunology. It presents studies on the basic mechanisms of both the specific and non-specific defense systems, the cells, tissues, and humoral factors involved, their dependence on environmental and intrinsic factors, response to pathogens, response to vaccination, and applied studies on the development of specific vaccines for use in the aquaculture industry.